Lenvatinib, toripalimab plus hepatic arterial infusion chemotherapy in patients with high-risk advanced hepatocellular carcinoma: A biomolecular exploratory, phase II trialZhiCheng Lai, Ming Shi, YeXing Huang et al.|European Journal of Cancer|2022Cited by 154
Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Sorafenib for Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization: Retrospective Subgroup Analysis of 2 Prospective TrialsYeXing Huang, Anna Kan, Lihong Zhang et al.|Technology in Cancer Research & Treatment|2022Cited by 8